Table 2 The occurrence, medication usage, complications and risk of AF in 243 patients
Characteristics | Value(%) |
|---|---|
Atrial fibrillation symptoms, n (%) | 229(94.2) |
Pathway of AF discovery, n (%) | Â |
 Health checkup | 179(73.7) |
 Others | 64(26.3) |
Course of atrial fibrillation, n (%) | Â |
 <2 years | 195(80.2) |
 2 ~ 5 years | 23(9.5) |
 >5 years | 25(10.3) |
Awareness of atrial fibrillation hazards, n(%) | 44(18.1) |
Use of anticoagulants, n(%) | 29(11.9) |
Types of anticoagulants, n(%) | Â |
 No | 197(81.1) |
 Warfarin | 16(6.6) |
 NOACs | 13(5.3) |
Use of antiplatelets | 17(7.0) |
Use of heart rate control drugs | 65(26.7) |
CHA2DS2-VASc score, n (%) | Â |
 High risk | 226(93.0) |
 Low/middle risk | 17(7.0) |
HAS-BLED score, n (%) | Â |
 High | 60(24.7) |
 Low/middle risk | 183(75.3) |
Previous thromboembolic events, n (%) | 25(10.3) |
 With anticoagulants | 3(1.2) |
Previous bleeding events, n (%) | 2(0.8) |
 With anticoagulants | 0(0.0) |